Table 2.
Characteristic | All Eligible Patients (N=570) | Patients with Tumors Exhibiting High-Frequency Microsatellite Instability (N=95) | Patients with Tumors Exhibiting Microsatellite Stability or Low-Frequency Microsatellite Instability (N=475) | P Value |
---|---|---|---|---|
Treatment — no. (%) | 0.19 | |||
Adjuvant chemotherapy | 283 (50) | 53 (56) | 230 (48) | |
No adjuvant chemotherapy | 287 (50) | 42 (44) | 245 (52) | |
| ||||
Age — yr | 59.8±11.2 | 60.7±13.0 | 59.7±10.8 | 0.13 |
| ||||
Sex — no. (%) | 0.45 | |||
Male | 326 (57) | 51 (54) | 275 (58) | |
Female | 244 (43) | 44 (46) | 200 (42) | |
| ||||
Stage of disease — no. (%) | 0.18 | |||
II | 312 (55) | 58 (61) | 254 (53) | |
III | 258 (45) | 37 (39) | 221 (47) | |
| ||||
Site of tumor — no. (%)† | <0.001 | |||
Proximal | 257 (45) | 84 (89) | 173 (36) | |
Distal | 305 (54) | 9 (10) | 296 (62) | |
Multiple | 6 (1) | 1 (1) | 5 (1) | |
| ||||
Tumor grade — no. (%)† | <0.001 | |||
Well differentiated (G1) | 97 (17) | 8 (9) | 89 (19) | |
Moderately differentiated (G2) | 376 (66) | 49 (53) | 327 (69) | |
Poorly differentiated (G3) | 65 (11) | 24 (26) | 41 (9) | |
Undifferentiated (G4) | 28 (5) | 12 (13) | 16 (3) | |
| ||||
No. of positive nodes — no. (%) | 0.21 | |||
0 | 312 (55) | 58 (61) | 254 (53) | |
1–4 | 128 (22) | 15 (16) | 113 (24) | |
>4 | 130 (23) | 22 (23) | 108 (23) | |
| ||||
Vital status at 8 yr — no. (%) | 0.03 | |||
Alive | 385 (68) | 73 (77) | 312 (66) | |
Dead | 185 (32) | 22 (23) | 163 (34) |
Plus–minus values are means ± SD. P values for the comparison between patients with tumors exhibiting high-frequency microsatellite instability and patients with tumors exhibiting microsatellite stability or low-frequency microsatellite instability were calculated by the chi-square test for all variables except the mean age at diagnosis, for which an unpaired t-test was used. Because of rounding, not all percentages total 100.
Data pertaining to the site of the tumor and the tumor grade are not available for all 570 patients.